Innate immunity against hematological malignancies

Area of Science:

• Immunology
• Transplantation Biology
• Hematology

Background:

• Allogeneic hematopoietic transplantation relies on T-cell responses for engraftment and graft-versus-leukemia (GvL) effects.
• T-cell depletion in HLA-mismatched transplants to prevent graft-versus-host disease (GvHD) raises concerns about GvL effects and reduced preparative regimens.
• Natural killer (NK) cells, regulated by MHC Class I, may offer an alternative alloreactive pathway.

Purpose of the Study:

• To evaluate the role of NK-cell alloreactivity in allogeneic hematopoietic stem cell transplantation.
• To determine if NK-cell alloreactivity can mitigate GvHD while preserving GvL effects in mismatched transplants.
• To explore the potential of NK-cell alloreactivity in reducing transplant conditioning intensity.

Main Methods:

• Evaluation of NK-cell alloreactivity in clinical hematopoietic stem-cell transplants.
• Assessment of NK-cell alloreactivity in murine models of MHC-mismatched transplantation.
• Analysis of the impact of donor-versus-recipient alloreactive NK cells on transplant outcomes.

Main Results:

• Clinical HLA Class I disparities triggering NK-cell alloreactions led to elimination of AML relapse and graft rejection.
• NK-cell alloreactions protected patients from GvHD in clinical settings.
• Pre-transplant infusion of alloreactive NK cells in murine models conditioned recipients and reduced GvHD.

Conclusions:

• NK-cell alloreactivity demonstrates significant potential in allogeneic hematopoietic stem cell transplantation.
• Harnessing NK-cell alloreactivity may enhance transplant efficacy by improving engraftment and GvL effects.
• NK-cell alloreactivity offers a novel strategy to improve the safety and effectiveness of transplantation, potentially reducing GvHD and relapse.